US Bancorp’s Tvardi Therapeutics TVRD Stock Holding History

US Bancorp’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.25K	Buy	+1,000	New	+$2.1K	﹤0.01%	4005
2024 Q4	–	Sell	-1	Closed	-$11	–	4287
2024 Q3	$11	Hold	1	–	–	﹤0.01%	4066
2024 Q2	$9	Hold	1	–	–	﹤0.01%	3960
2024 Q1	$32	Hold	1	–	–	﹤0.01%	3939
2023 Q4	$26	Hold	1	–	–	﹤0.01%	3940
2023 Q3	$59	Hold	1	–	–	﹤0.01%	3947
2023 Q2	$99	Sell	1 -3	-75%	-$413	﹤0.01%	3942
2023 Q1	$707	Sell	4 -3	-43%	-$1K	﹤0.01%	3914
2022 Q4	$2.81K	Hold	7	–	–	﹤0.01%	3688
2022 Q3	$2K	Buy	7 +6	+600%	+$2.17K	﹤0.01%	3879
2022 Q2	$0	Hold	1	–	–	﹤0.01%	4268
2022 Q1	$0	Hold	1	–	–	﹤0.01%	4231
2021 Q4	$0	Sell	1 -1	-50%	-$502	﹤0.01%	4251
2021 Q3	$1K	Hold	2	–	–	﹤0.01%	4035
2021 Q2	$1K	Buy	+2	New	+$1.27K	﹤0.01%	3959
2020 Q4	–	Sell	-6	Closed	-$3K	–	3905
2020 Q3	$3K	Hold	6	–	–	﹤0.01%	3449
2020 Q2	$3K	Hold	6	–	–	﹤0.01%	3457
2020 Q1	$3K	Sell	6 -27	-82%	-$14.7K	﹤0.01%	3407
2019 Q4	$19K	Hold	33	–	–	﹤0.01%	2911
2019 Q3	$22K	Sell	33 -28	-46%	-$23.3K	﹤0.01%	2808
2019 Q2	$48K	Hold	61	–	–	﹤0.01%	2547
2019 Q1	$44K	Hold	61	–	–	﹤0.01%	2544
2018 Q4	$29K	Buy	61 +28	+85%	+$18.1K	﹤0.01%	2681
2018 Q3	$29K	Buy	33 +19	+136%	+$13.7K	﹤0.01%	2802
2018 Q2	$10K	Hold	14	–	–	﹤0.01%	3144
2018 Q1	$6K	Buy	14 +11	+367%	+$5.34K	﹤0.01%	3297
2017 Q4	$1K	Hold	3	–	–	﹤0.01%	3560
2017 Q3	$1K	Sell	3 -14	-82%	-$7.01K	﹤0.01%	3521
2017 Q2	$10K	Buy	+17	New	+$10.8K	﹤0.01%	3066

Other funds holding TVRD

Brookstone Capital Management Wheaton, Illinois $10.1B AUM 17.94% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

US Bancorp's TVRD Position: Q3 2026 in Review

US Bancorp opened a new position in Tvardi Therapeutics (TVRD) in Q3 2026: 1,000 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #4005 among its holdings. This is a return to the name: US Bancorp previously reported a position in TVRD as recently as Q3 2024.

US Bancorp first reported a position in TVRD in Q2 2017 and has held it in 29 quarters since. The position peaked at $48K in Q2 2019. 16 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.

US Bancorp held 1,000 shares of Tvardi Therapeutics worth $1.25K as of Q3 2026.
Tvardi Therapeutics was a new US Bancorp position in Q3 2026.
Tvardi Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #4005 holding.
US Bancorp first reported a position in Tvardi Therapeutics in Q2 2017 and has held it in 29 quarters since.
US Bancorp's Tvardi Therapeutics position peaked at $48K in Q2 2019.
16 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.